Propel Bio Management »

Artiva Biotherapeutics shares owned by Propel Bio Management

Quarter-by-quarter ownership of Artiva Biotherapeutics (ARTV) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Artiva Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Artiva Biotherapeutics held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Artiva Biotherapeutics by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $950k 146k 6.49

More positions owned by Propel Bio Management

Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Achieve Life Sciences (ACHV)
Phathom Pharmaceuticals (PHAT)
Delcath Sys Com New (DCTH)
Corcept Therapeutics Incorporated (CORT)
Abeona Therapeutics Com New (ABEO)
Vor Biopharma Com New (VOR)
Kyverna Therapeutics (KYTX)
Milestone Pharmaceuticals (MIST)
Celldex Therapeutics Com New (CLDX)
Compass Pathways Sponsored Ads (CMPS)
Miragen Therapeutics (VRDN)
Inventiva Sa Ads (IVA)
Sab Biotherapeutics Com New (SABS)
Health Sciences Acq Corp 2 (OBIO)

View all positions for Propel Bio Management

Top funds holding Artiva Biotherapeutics

RA Capital Management
5AM Venture Management
VR Adviser
venBio Partners
Franklin Resources
Revelation Capital Management
Vanguard Group
BlackRock
Vanguard Capital Management
Wellington Management Company
Propel Bio Management
Millennium Management
Renaissance Technologies
Two Sigma Investments
Geode Capital Management

View all funds holding Artiva Biotherapeutics